“Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals”, Journal of Pharmaceutical Negative Results, pp. 921–929, Nov. 2022, Accessed: Jun. 06, 2026. [Online]. Available: https://www.pnrjournal.com/index.php/home/article/view/3403